Published • loading... • Updated
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit
The complaint says GeneDx misled investors about Fabric Genomics, margin pressure and reimbursement rates, and seeks damages for securities losses.
- On Monday, July 13, 2026, Bronstein, Gewirtz & Grossman, LLC announced a class action lawsuit against GeneDx Holdings Corp. alleging material misrepresentations regarding Fabric Genomics during the Class Period.
- The complaint alleges that GeneDx failed to disclose significant problems with Fabric Genomics' viability, which negatively impacted the company's gross margins and average reimbursement rates.
- GeneDx repeatedly claimed the Fabric acquisition would improve financials and create efficiencies, though the lawsuit alleges defendants knew of or recklessly disregarded significant problems in Fabric's viability.
- Investors who suffered losses between April 16, 2025, and May 4, 2026, have until August 3, 2026, to request that the Court appoint them as lead plaintiff.
- Bronstein, Gewirtz & Grossman, LLC represents GeneDx investors on a contingency fee basis, meaning the firm will ask the Court to reimburse expenses and attorney fees only if the litigation is successful.
Insights by Ground AI
45 Articles
45 Articles
InsideNoVA.com+39 Reposted by 39 other sources
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit
NEW YORK, July 12, 2026 /PRNewswire/ -
·Washington, United States
Read Full Article
Bronstein, Gewirtz & Grossman LLC Urges Megan Holdings Limited Investors to Act: Class Action Filed Alleging Investor Harm
NEW YORK, July 12, 2026 /PRNewswire/ --Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Megan Holdings Limited (NASDAQ: MGN) and certain of its officers.
·Madison, United States
Read Full Article
Coverage Details
Total News Sources45
Leaning Left4Leaning Right4Center33Last UpdatedBias Distribution80% Center
Bias Distribution
- 80% of the sources are Center
80% Center
C 80%
Factuality
To view factuality data please Upgrade to Premium
